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Kidney Res Clin Pract 31 (2012) A16–A96A30pressure were independent predictors of CKD in multivariate analysis.
There was a graded relationship between the number of MetS traits and the
presence of CKD and also between MetS traits and ACR.
In conclusion, CKD is prevalent in patients with the metabolic syndrome
and may be due to a synergistic effect of the various components of the
syndrome. Diastolic blood pressure and obesity may predict CKD in MetS
patients. Albuminuria may also be prevalent in MetS patients; increasing
with increasing number of MetS traits.
http://dx.doi.org/10.1016/j.krcp.2012.04.37855
PREVALENCE OF HOSPITAL MALNUTRITION IN RENAL PATIENTS
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The prevalence of protein energy wasting varies enormously depending
on deﬁnition and parameters used. Most evidence include clinical stable
patients only. There is few evidence in pre dialysis patients. The purpose of
this study was to assess nutritional status at hospital admittance of renal
patients NKF-DOQI 2–5 predialysis and dialysis patients and its association
with morbidity and mortality. Nutritional assessment was done during the
ﬁrst three days of admission to the hospital with a composite nutritional
index in 907 renal patients (589 pre dialysis and 318 dialysis). Length of
stay and frequency of hospitalizations, mortality and comorbidities were
registered. ANOVA, Cox and Kaplan-Meier statistics were done where
needed. A prevalence of 76% of moderate to severe malnutrition was found
to the general population being more prevalente in dialysis patients (81%
dialysis vs 73% pre dialysis) (pr0.05). Hazard ration of malnutrition was
2.07 and 2.57 in DOQI 4 and 5 non dialysis patients respectively (po0.05).
Hazard ratio of mortality was 2.91 and 8.67 in moderate and severe
malnutrition respectively predialysis patients (po0.05) and 2.72 and 3.22
in moderate and severe malnutrition respectively in dialysis patients
(po0.05). Survival during the follow up was inferior in severe malnutrition
in both groups (po0.05). In conclusion a prevalence of 76% of malnutrition
was found in this cohort of hospitalized renal patients, greater than
reported elsewhere being in dialysis patients more prevalent. Malnutrition
was negatively associated with survival.
nCorresponding author.
http://dx.doi.org/10.1016/j.krcp.2012.04.37956
CALCINEURIN A (CA) INHIBITION SUPRESSES PROTEIN SYNTHESIS VIA
AMP DEPENDENT KINASE (AMPK).
H. Franch, C. Ding, S. Zoromsky, S. Williams, J. Gooch
Atlanta VAMC & Emory University, Decatur & Atlanta, GA, USA.
Diabetes stimulates CA activity in the kidney and CA inhibitor
cyclosporine A (CYA) or CAb isoform knock-out (CAb -/-) block diabetic
renal hypertrophy.CA regulates the mammalian target of rapamycin
(mTOR) to reduce protein synthesis (PS) during cardiac hypertrophy.To
study this pathway, NRK-52E and SV40 transformed CAb þ/þ and -/-
proximal tubule cell lines were treated with 10 nM epidermal growth
factor (EGF) and/or 8 mM CYA. After 48 hrs of CYA in NRK-52E cells, EGF-
induced protein/well was 3074% lower with decreased PS (4972%) rather
than increased protein breakdown. In CAb -/- cells, protein/well (20þ2%)
and PS (16 71%) were lower and CYA did not decrease PS further. In
CAbþ/þ cells, CYA reduced PS 20þ2%. However, CYA did not block mTOR
signaling as measured by phosphorylation (P) at S2448 or by p70S6 kinase
P at T389. CYA also did not alter the mTOR dependent pathway of
macroautophagy. However, CYA in NRK-52E or CAb -/- cells showed
increased activation of the metformin-sensitive energy sensor, AMPK, as
measured by P of T172 by 5- or410-fold, respectively. AMPK reduces PS
via P of eukaryotic elongation factor 2 (eEF2) at T356 and CYA increased
eEF2 P by3 fold.We conclude CA inhibition reduces PS in renal
hypertrophy via a novel pathway involving AMPK and eEF2 rather than by
mTOR and p70S6 kinase. Activation of AMPK or altered energy metabolism
via CAb may be important in CA inhibitor nephrotoxicity.
http://dx.doi.org/10.1016/j.krcp.2012.04.38057
HIGH PROTEIN DIETS STIMULATE RENAL PROTEIN OXIDATION IN
EXPERIMENTAL DIABETES.
H. Franch, S. Zoromsky, S. Williams, C. Din
Atlanta VAMC & Emory University, Decatur & Atlanta, GA, USA.
Calorie restriction increases macro- and chaperone-mediated autophagy
(MA & CMA) protecting against organ damage by destroying oxidized
proteins (OX) and p62/sequestisome 1 labeled aggregates (p62). Altering
dietary protein changes kidney damage in DM, but the effect on renal
cortical MA, CMA, OX and p62 is unknown. 60 mg/kg streptozotocin
Diabetic (D) Sprague-Dawley rats (200 g) or control (C) were fed isocaloric
12% (L), 23% (M) or 40% (H) protein diets for 21 days (6 groups, each n¼
7-11). Body weight at 21 days was 16-22% lower than C in all D rats
(po0.01, NS between diets). Blood glucose was lower in DH vs. DL diets
(408þ25vs. 482þ23 mg/dl, po0.05). Kidney wt/body wt increased in all
DM groups, but increase was greater in DH than DL (104þ13 vs. 66þ11%,
po0.02). MA, CMA, and p62 were estimated by western blotting for light
chain 3b II/I ratio, lysosome associated membrane protein 2a, and p62
respectively, while OX was measured by Oxyblot. D reduced CMA by 65-
76% (po0.05 vs. C) while H diet reduced it by 45% in C and D rats (NS).
MA increased in all D, but was 10 fold higher in HD vs. HC or LD
(po0.02). There was a trend toward increased OX with D, but only HD
reached signiﬁcance vs. all C (95þ32%, po0.05). The trend for p62 to
increase with D or H was NS. We conclude that despite lower glucose, H
diets worsen diabetic renal hypertrophy and cortical OX possibly by
suppressing CMA. Increases in MA by D and H prevent p62 protein
aggregates from accumulating.
http://dx.doi.org/10.1016/j.krcp.2012.04.38158
SERUM OMEGA-3 FATTY ACID LEVELS IN A LARGE INCIDENT U.S.
HEMODIALYSIS POPULATION
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Long chain omega-3 (n-3 PUFA) fatty acids may inﬂuence clinical outcomes
in hemodialysis patients. We therefore performed the largest characterization
to date of n-3 PUFA levels in an incident hemodialysis population.
Serum n-3 PUFA were measured in samples obtained at baseline in a 400
person subgroup of the ArMORR study, a large representative cohort of U.S.
incident hemodialysis patients. n-3 PUFA were measured by gas
chromatography, with phospholipid (PL) and triglyceride (TG) fatty acids being
separated by solid phase extraction. Signed rank test was used to compare PL
and TG fractions.
Mean (7SD) age was 66714 years and body mass index 2677 kg/m2.
58% were men and 68% white. Cause of ESRD was diabetes and hypertension in
47% and 40% of subjects, respectively. Total serum 20:5n-3 (EPA) (by mean
weight %) was 0.0970.36 (PL vs. TG: 0.0970.43 vs. 0.0770.30, p¼0.14), and
total serum 22:6n-3 (DHA) was 1.4670.72 (PL vs. TG: 3.0371.24 vs.
0.2170.40, po0.001). Minimal 22:5n-3 (DPA) was detected. Total long chain
n-3 PUFA levels were 1.5570.95 (PL vs TG: 3.1371.47 vs. 0.2870.64,
po0.001).
In summary, n-3 PUFA levels in this large U.S. cohort are low relative to
published reports of levels in the general population or even in hemodialysis
patients outside the U.S., making this a potential target for intervention.1 In
addition, future enquiries into n-3 PUFA in hemodialysis cohorts should focus
on the phospholipid fraction since we have demonstrated that, similar to the
general population, this is where they primarily accumulate.
http://dx.doi.org/10.1016/j.krcp.2012.04.382
